Programme SOM0044 for Parkinson’s Disease
SOM0044 is a small molecule for the treatment of Parkinson’s disease.
Pfizer and Astellas report positive results of Xtandi in cancer
Pfizer partnered with Astellas Pharma to develop Xtandi for the treatment of prostate cancer. Credit: Lauri Silvennoinen.
Learn more
Hover over the logos to learn more about the companies who made this project possible.
Close
-
Kognitic
Kognitic Clinical Trial Intelligence (CTI) is an automated and robust,...
About
Kognitic Clinical Trial Intelligence (CTI) is an automated and robust, insight-driven platform for life sciences, which accelerates our clients' drug development pipeline and investment decisions.
FollowMake an Enquiry
-
VaLea Clinical Trials
VaLea Clinical Trials specialises in providing convenient patient-centric services for...
About
VaLea Clinical Trials specialises in providing convenient patient-centric services for clinical trials in the home or alternate-site settings, based in Vienna, Austria.
FollowMake an Enquiry
-
SOM Biotech
SOM Biotech is an Artificial Intelligence AI drug discovery and...
About
SOM Biotech is an Artificial Intelligence AI drug discovery and development company focused on the development of therapies for orphan indications through the proprietary AI-based drug discovery technology.
FollowMake an Enquiry